LVAD Experts Respond To Thoratec HeartMate II Safety Alert
This article was originally published in The Gray Sheet
Health care providers treating patients with a Thoratec HeartMate II left-ventricular assist device should not let the patients switch to the new Pocket Controller until they are completely trained on how to hook-up the new system, experts familiar with the devices say. Ideally, the patients will come into the physician’s office to make the switch.
You may also be interested in...
Thoratec Warns Of Potentially Lethal Complications When Patients Switch To New HeartMate II Controller
Serious adverse events have been linked to patients struggling to switch their Thoratec HeartMate II left-ventricular assist devices from an older controller system to the newer Pocket Controller system. The company is updating the labeling and training materials for the system and warning doctors and patients to communicate to ensure they understand how to convert to the Pocket Controller.
A combined final opinion on the European Chemicals Agency’s proposed microplastic restriction is expected from ECHA committees by year-end, at which point the European Commission will consider whether and when microplastic must be removed from all leave-on cosmetic products marketed in the EU.
Butterfly Network’s CEO Laurent Faracci outlines the company’s growth strategy and plans for their “ultrasound-on-a-chip” technology after its merger with blank check company Longview Acquisition Corp. See what the company’s CEO said about it here.